354 related articles for article (PubMed ID: 22228254)
1. Screening for familial hypercholesterolaemia.
Bender R; Bell DA; Hooper AJ; Edwards G; van Bockxmeer FM; Watts GF; Burnett JR
Pathology; 2012 Feb; 44(2):122-8. PubMed ID: 22228254
[TBL] [Abstract][Full Text] [Related]
2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
3. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.
Austin MA; Hutter CM; Zimmern RL; Humphries SE
Am J Epidemiol; 2004 Sep; 160(5):407-20. PubMed ID: 15321837
[TBL] [Abstract][Full Text] [Related]
4. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
Bourbon M; Rato Q;
Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
[TBL] [Abstract][Full Text] [Related]
5. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
[TBL] [Abstract][Full Text] [Related]
6. Opportunistic screening for familial hypercholesterolaemia via a community laboratory.
Bell DA; Hooper AJ; Bender R; McMahon J; Edwards G; van Bockxmeer FM; Watts GF; Burnett JR
Ann Clin Biochem; 2012 Nov; 49(Pt 6):534-7. PubMed ID: 23002132
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece.
Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M
Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044
[TBL] [Abstract][Full Text] [Related]
8. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
[TBL] [Abstract][Full Text] [Related]
9. An APEX-based genotyping microarray for the screening of 168 mutations associated with familial hypercholesterolemia.
Dušková L; Kopečková L; Jansová E; Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
Atherosclerosis; 2011 May; 216(1):139-45. PubMed ID: 21310417
[TBL] [Abstract][Full Text] [Related]
10. Cascade genetic screening for familial hypercholesterolemia.
Leren TP
Clin Genet; 2004 Dec; 66(6):483-7. PubMed ID: 15521974
[TBL] [Abstract][Full Text] [Related]
11. [Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening].
Sinan ÜY; Sansoy V
Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():1-9. PubMed ID: 25693358
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
[TBL] [Abstract][Full Text] [Related]
13. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
[TBL] [Abstract][Full Text] [Related]
14. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.
Wiegman A; Gidding SS; Watts GF; Chapman MJ; Ginsberg HN; Cuchel M; Ose L; Averna M; Boileau C; Borén J; Bruckert E; Catapano AL; Defesche JC; Descamps OS; Hegele RA; Hovingh GK; Humphries SE; Kovanen PT; Kuivenhoven JA; Masana L; Nordestgaard BG; Pajukanta P; Parhofer KG; Raal FJ; Ray KK; Santos RD; Stalenhoef AF; Steinhagen-Thiessen E; Stroes ES; Taskinen MR; Tybjærg-Hansen A; Wiklund O;
Eur Heart J; 2015 Sep; 36(36):2425-37. PubMed ID: 26009596
[TBL] [Abstract][Full Text] [Related]
15. A novel LDLR mutation, H190Y, in a Utah kindred with familial hypercholesterolemia.
Hopkins PN; Wu LL; Stephenson SH; Xin Y; Katsumata H; Nobe Y; Nakajima T; Hirayama T; Emi M; Williams RR
J Hum Genet; 1999; 44(6):364-7. PubMed ID: 10570905
[TBL] [Abstract][Full Text] [Related]
16. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia.
Langslet G; Ose L
Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1061-6. PubMed ID: 23984929
[TBL] [Abstract][Full Text] [Related]
17. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia.
Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D
J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of the atherogenic Lp(a) are elevated in FH.
Lingenhel A; Kraft HG; Kotze M; Peeters AV; Kronenberg F; Kruse R; Utermann G
Eur J Hum Genet; 1998 Jan; 6(1):50-60. PubMed ID: 9781014
[TBL] [Abstract][Full Text] [Related]
19. Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease.
Yudi M; Omera L; McCubbery N; Dick S; Jayasinghe R; Hamilton-Craig I
Singapore Med J; 2012 Mar; 53(3):174-8. PubMed ID: 22434290
[TBL] [Abstract][Full Text] [Related]
20. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ
Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
